Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib
暂无分享，去创建一个
K. Gould | J. Lopez-Mattei | D. Balanescu | T. Donisan | N. Palaskas | P. Kim | Saamir A Hassan | C. Iliescu | S. Arain | Kaveh Karimzad | Daryl Sudasena | Nicolas L. Palaskas | Peter Y Kim